Business OpportunityUpdated on 20 March 2026
Erb-eVax
CEO at Evvivax srl
Roma, Italy
About
Erb-eVax is a therapeutic vaccine intended for tumors in veterinary models and humans that express the HER2/ErbB2 receptor. This platform has shown superior efficacy in dog studies and could be extended to humans.
Similar opportunities
Business Opportunity
- AI
- TRL 7
- Oncology
- Diagnostics
- Bioinformatics
- Clinical validation
- Consortium partners
- Neoplasms/cancer/oncology
Marc Vargas
Project Manager in Digital Pathology at Palex
Barcelona, Spain